Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

US: Cannabis Science CEO to speak at Harvard Medical School

Cannabis Science's President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Additionally, Cannabis Science's Chief Medical Officer (CMO), Allen Herman, will Co-Chair a special session at the GHC Summit. Both Dabney and Herman previously presented at Harvard Medical School in November 2016.

Dabney will be the keynote speaker and a panelist for a special session on "Cannabis Science Versus Cancer and Other Malignancies." Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science's vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.

Additionally, Dabney will present summit participants with an overview of the company's current drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). In addition to co-chairing the session, Herman will participate in the discussion on the epidemiology of cancer and the utilization of opioids in Africa as opioid utilization rates reflect the pain divide. This conference affords Cannabis Science an opportunity to discuss cutting-edge cannabinoid research with some of the greatest minds in modern medicine globally, as well as to network and explore potential partnerships. In addition, through participation in this Summit, Cannabis Science will give updates on progress in the implementation of Cannabis Science's research agreement with Dana-Farber and a potential consortium agreement involving other institutions.

On January 3, 2017, Cannabis Science entered into a CRA with Dana-Farber, one of the world's leading cancer centers. Under the terms of the CRA, Cannabis Science and Dana-Farber will jointly investigate and develop use of cannabinoids to treat various forms of cancers.

"I am excited about Cannabis Science's relationship with Dana-Farber. When I first met Wilfred Ngwa, PhD, Director of Global Health Catalyst at Harvard Medical School and Principal Investigator for the CRA, we immediately realized potential synergies on cancer research interests, and the potential to collaborate to develop cannabinoid-based medicines to treat cancer and control cancer symptoms with minimal side-effects," stated Dabney.

Dabney and Ngwa met during the Constituency for Africa's (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC in September 2016, where they both were on the speaking program. Mr. Dabney is a Member of the Board of Directors of CFA, and the Vice Chairman of CFA's African Healthcare Infrastructure Committee (AHIC).

For more information:

Publication date: 3/8/2017



Other news in this sector:

3/23/2018 US (CA): Marapharm to expedite greenhouse cultivation facility
3/22/2018 Affinor Growers to begin cannabis grow trial
3/22/2018 US (MA): Future Farm to build 24,700 sq.ft. MMJ facility
3/21/2018 Bankrupt Danish nursery turning into Spectrum Cannabis
3/16/2018 US: Indoor Harvest forms scientific advisory board
3/15/2018 CAN (ON): Job growth skyrockets as MJ industry ramps up
3/14/2018 CAN (ON): Aphria adds 200,000 sq.ft. to triple production
3/13/2018 CAN (NL): Canopy Growth secures cannabis site
3/12/2018 Jamaica's first legal MMJ facility opens
3/12/2018 US (CA): Calaveras County MMJ growers face ban
3/9/2018 US (CA): MMJ sales are escalating, along with growers' energy costs
3/9/2018 Meet Canada's marijuana moguls
3/8/2018 "America is giving away the $30 billion medical marijuana industry"
3/8/2018 Prepping the largest cannabis grow in Canada
3/8/2018 US (WA): 28,000 sq.ft. MMJ facility nears completion
3/7/2018 UN report reveals UK is world’s biggest producer of medical cannabis
3/7/2018 "There really is no such thing as medical marijuana"
3/6/2018 CAN (BC): Village Farms starts 1.1 million sq.ft. cannabis cultivation
3/5/2018 CAN (BC): 26,000 sq.ft. MMJ greenhouse planned on Gabriola Island
3/2/2018 US (ME): 35,000 sq.ft. MMJ farm for sale